Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05836701 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Retrospective Study of Germ Cell Tumors of the Central Nervous System

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 15, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Dec 31, 2023 to Dec 31, 2024
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v4
  2. Start date changed from estimate of May 1, 2023 to Jun 1, 2023v3
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Retrospectively analyzing the epidemiological and clinical characteristics, treatment, recurrence, prognosis and prognostic factors of the germ-cell tumors of central nervous system in a single center.
Trial Details
NCT Number NCT05836701
Lead Sponsor Beijing Sanbo Brain Hospital
Conditions
(from sponsor)		 Germ Cell Tumor of CNS
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov